Or Refractory Chronic Myelomonocytic Leukemia
📧 Sign up to get email alerts when something new happens for Or Refractory Chronic Myelomonocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002) [Phase 1]
A Phase 1 study evaluating MK-0482 for relapsed or refractory acute myeloid leukemia and relapsed or refractory chronic myelomonocytic leuke…